Population pharmacokinetic analysis of doxecitine and doxribtimine in patients with thymidine kinase 2 deficiency and in healthy volunteersPAGE 33 (2025) Abstr 11353 Bouchene S, Mittur A, Naik H, Dua P, Neldemo I, Ribbing J, Bergstrand M, Khandelwal A.ConferenceGeneticPharmacometricsPhase IIRegulatory interactionsPharmetheus Affiliates Senior Director, MIDD ConsultantIda NeldemoSee bio Principal Director, MIDD Consultant & Senior ExpertJakob RibbingSee bio Principal Director, MIDD Scientific LeadMartin BergstrandSee bio
